The histamine-cytokine network in allergic inflammation

Journal of Allergy and Clinical Immunology

Volumn 112, Issue 4 SUPPL., 2003, Pages

  Marone, Gianni ^a,b   Granata, Francescopaolo ^a   Spadaro, Giuseppe ^a   Genovese, Arturo ^a   Triggiani, Massimo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Antihistamines; Basophils; Fexofenadine; Histamine; Macrophages; Mast cells

Indexed keywords

ANTIHISTAMINIC AGENT; BETA GLUCURONIDASE; CYTOKINE; FEXOFENADINE; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; HISTAMINE H3 RECEPTOR; HISTAMINE H4 RECEPTOR; INTERLEUKIN 6; RANITIDINE; TERFENADINE;

ALLERGIC ASTHMA; ALLERGIC REACTION; ALLERGIC RHINITIS; ALLERGY; BASOPHIL; CELL INTERACTION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CYTOKINE PRODUCTION; EOSINOPHIL; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFLAMMATION; LUNG PARENCHYMA; MACROPHAGE; MAST CELL; MONOCYTE; NERVE CELL; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN FUNCTION; SEDATION; SIDE EFFECT; T LYMPHOCYTE; TISSUE INJURY;

EID: 0141953269     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(03)01881-5     Document Type: Conference Paper

References (67)

1. Marone G. Human basophils and mast cells: biological aspects. Basel. Switzerland: Karger; 1995.
2. Marone G. Human basophils and mast cells: clinical aspects. Basel, Switzerland: Karger; 1995.
3. Dale HH, Laidlaw PP. The physiological action of beta-imidazolyl-ethylamine. J Physiol 1910;41:318-44.
4. Marone G, Casolaro V, Patella V, Florio G, Triggiani M. Molecular and cellular biology of mast cells and basophils. Int Arch Allergy Immunol 1997;114:207-17.
5. H3 region of IgE. J Immunol 1998;161:5647-55.
6. Marone G, de Crescenzo G, Florio G, Granata F, Dente V, Genovese A. Immunological modulation of human cardiac mast cells. Neurochem Res 1999;24:1195-202.
7. de Paulis A, Minopoli G, Arbustini E, de Crescenzo G, Dal Piaz F, Pucci P, et al. Stem cell factor is localized in, released from, and cleaved by human mast cells. J Immunol 1999;163:2799-808.
8. Bochner BS, Lichtenstein LM. Anaphylaxis. N Engl J Med 1991; 324:1785-90.
9. Triggiani M, Schleimer RP, Warner JA, Chilton FH. Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells. J Immunol 1991;147:660-6.
10. Dale HH, Laidlaw PP. Histamine shock. J Physiol 1919;52:355-90.
11. Bouvet D, Staub AM. Action protectrice des ethers phenoliques au cours de l'intoxication histaminique. Comp Rend Soc Biol 1937;124:547-9.
12. Staub A, Bouvet D. Action de la thymoxyethyldiethylamine (929 F) et des ethers phenoliques sur le choc anaphylactique du cobaye. Comp Rend Soc Biol 1937;125:818-23.
13. Halpern B. Les antihistaminiques de synthese: essais de chimotherapie des etats allergiques. Arch Int Pharmacodyn Therap 1942;68:339-408.
14. Ash AS, Schild HO. Receptors mediating some actions of histamine: 1966. Br J Pharmacol 1997;120:302-14.
15. Wenzel SE, Fowler AA, Schwartz LB. Activation of pulmonary mast cells by bronchoalveolar allergen challenge: in vivo release of histamine and tryptase in atopic subjects with and without asthma. Am Rev Respir Dis 1988;137:1002-8.
16. Casolaro V, Galeone D, Giacummo A, Sanduzzi A, Melillo G, Marone G, Human basophil/mast cell releasability. V. Functional comparisons of cells obtained from peripheral blood, lung parenchyma, and bronchoalveolar lavage in asthmatics. Am Rev Respir Dis 1989;139:1375-82.
17. Charlesworth EN, Kagey-Sobotka A, Schleimer RP, Norman PS, Lichtenstein LM. Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen. J Immunol 1991;146:671-6.
18. Lawrence ID, Warner JA, Cohan VL, Hubbard WC, Kagey-Sobotka A, Lichtenstein LM. Purification and characterization of human skin mast cells: evidence for human mast cell heterogeneity. J Immunol 1987;139:3062-9.
19. Patella V, Marinò I, Lamparter B, Arbustini E, Adt M, Marone G. Human heart mast cells: isolation, purification, ultrastructure, and immunologic characterization. J Immunol 1995;154:2855-65.
20. Liu MC, Hubbard WC, Proud D, Stealey BA, Galli SJ, Kagey-Sobotka A, et al. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics: cellular, mediator, and permeability changes. Am Rev Respir Dis 1991;144:51-8.
21. Koshino T, Teshima S, Fukushima N, Takaishi T, Hirai K, Miyamoto Y, et al. Identification of basophils by immunohistochemistry in the airways of post-mortem cases of fatal asthma. Clin Exp Allergy 1993;23:919-25.
22. Charlesworth EN, Hood AF, Soter NA, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Cutaneous late-phase response to allergen: mediator release and inflammatory cell infiltration. J Clin Invest 1989;83:1519-26.
23. Lagier B, Lebel B, Bousquet J, Pene J. Different modulation by histamine of IL-4 and interferon-gamma (IFN-γ) release according to the phenotype of human Th0, Th1 and Th2 clones. Clin Exp Immunol 1997;108:545-51.
24. 2 receptors. J Exp Med 1991;174:281-4.
25. 2 receptors. J Clin Invest 1998;102:1866-73.
26. 2 receptors. J Immunol 1998;161:2586-93.
27. 3 receptors: stimulation of IL-10 production. J Immunol 2000;164:2964-70.
28. Kohka H, Nishibori M, Iwagaki H, Nakaya N, Yoshino T, Kobashi K, et al. Histamine is a potent inducer of IL-18 and IFN-γ in human peripheral blood mononuclear cells. J Immunol 2000;164:6640-6.
29. Carlsson R, Dohlsten M, Sjogren HO. Histamine modulates the production of interferon-γ and interleukin-2 by mitogen-activated human mononuclear blood cells. Cell Immunol 1985;96:104-12.
30. 2-receptors in peripheral blood mononuclear cells. J Biol Chem 1994;269:9952-6.
31. 2 histamine receptors. Immunology 1980;41:107-14.
32. 1)-receptor radioligand binding studies on normal T cell subsets, B cells, and monocytes. J Immunol 1986;136:2116-20.
33. 4) expressed in bone marrow. Mol Pharmacol 2001;59:420-6.
34. Nguyen T, Shapiro DA, George SR, Setola V, Lee DK, Cheng R, et al. Discovery of a novel member of the histamine receptor family. Mol Pharmacol 2001;59:427-33.
35. Zhu Y, Michalovich D, Wu H, Tan KB, Dytko GM, Mannan IJ, et al. Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol Pharmacol 2001;59:434-41.
36. Raible DG, Lenahan T, Fayvilevich Y, Kosinski R, Schulman ES. Pharmacologic characterization of a novel histamine receptor on human eosinophils. Am J Respir Crit Care Med 1994;149:1506-11.
37. 2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma. Am Rev Respir Dis 1990;142:126-32.
38. Jarjour NN, Calhoun WJ, Schwanz LB, Busse WW. Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with increased airway obstruction. Am Rev Respir Dis 1991;144:83-7.
39. Triggiani M, Oriente A, Marone G. Differential roles for triglyceride and phospholipid pools of arachidonic acid in human lung macrophages. J Immunol 1994;152:1394-403.
40. Merchant RK, Schwanz DA, Helmers RA, Dayton CS, Hunninghake GW. Bronchoalveolar lavage cellularity: the distribution in normal volunteers. Am Rev Respir Dis 1992;146:448-53.
41. Triggiani M, De Marino V, Sofia M, Faraone S, Ambrosio G, Carratù L, et al. Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage. Am J Respir Crit Care Med 1997;156:94-100.
42. Pesci A, Foresi A, Bertorelli G, Chetta A, Olivieri D, Oliveri D. Histochemical characteristics and degranulation of mast cells in epithelium and lamina propria of bronchial biopsies from asthmatic and normal subjects. Am Rev Respir Dis 1993;147:684-9.
43. 1)-receptor increases beta-glucuronidase release from human lung macrophages. Am J Respir Cell Mol Biol 1990;3:603-9.
44. 1-receptors. J Immunol 2001;166:4083-91.
45. 2-receptors. In: Schwarts JC, Haas H, editors. The histamine receptor. New York: Wiley-Liss; 1992.
46. 2 antihistamines on "allergic" histamine release and its inhibition by histamine. J Pharmacol Exp Ther 1975;192:441-50.
47. Hojo M, Hamasaki Y, Fujita I, Koga H, Matsumoto S, Miyazaki S. Effects of anti-allergy drugs on fMet-Leu-Phe-stimulated superoxide generation in human neutrophils. Ann Allergy 1994;73:21-6.
48. Patella V, de Crescenzo G, Marino O, Spadaro G, Genovese A, Marone G. Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells. Int Arch Allergy Immunol 1996;111:23-9.
49. + cells. Clin Exp Allergy 1997;27:559-67.
50. Piacentini GL, Peroni DG, Sette L, Bonizzato C, Benedetti M, Boner AL. Inhibition of different dosages of oxatomide or placebo on skin prick test and nasal allergen provocation. J Allergy Clin Immunol 1991;88:218-25.
51. 1-receptor blockade on the early and late response to cutaneous allergen challenge. J Pharmacol Exp Ther 1992;262:964-70.
52. White MV, Slater JE, Kaliner MA. Histamine and asthma. Am Rev Respir Dis 1987;135:1165-76.
53. Casale TB, Wood D, Richerson HB, Trapp S, Metzger WJ, Zavala D, et al. Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness. J Clin Invest 1987;79:1197-203.
54. Herxheimer H. Antihistamines in bronchial asthma. BMJ 1949;2:901-4.
55. Crimi N, Oliveri R, Polosa R, Pulvirenti G, Prosperini G, Palemo F, et al. Effect of oral terfenadine on bronchoconstrictor response to inhaled neurokinin A and histamine in asthmatic subjects. Eur Respir J 1993;6:1462-7.
56. 1-receptor blocker cetirizine compared with other second-generation antihistamines. Mol Pharmacol 1998;54:113-21.
57. Taglialatela M, Castaldo P, Pannaccione A, Giorgio G, Genovese A, Marone G, et al. Cardiac ion channels and antihistamines: possible mechanisms of cardiotoxicity. Clin Exp Allergy 1999;29(suppl 3):182-9.
58. 1-receptor-antagonist drugs. N Engl J Med 1994;330:1663-70.
59. 1-receptor antagonists in allergic diseases. New York: Marcel Dekker Inc; 1996. p. 251-71.
60. 1-receptor antagonist, terfenadine, in chronic severe asthma. Br J Clin Pharmacol 1995;39:671-5.
61. Busse WW, Middleton E, Storms W, Dockhorn RJ, Chu TJ, Grossman J, et al. Corticosteroid-sparing effect of azelastine in the management of bronchial asthma. Am J Respir Crit Care Med 1996;153:122-7.
62. Canny GJ, Reisman J, Levison H. Does ketotifen have a steroid-sparing effect in childhood asthma? Eur Respir J 1997;10:65-70.
63. Grant JA, Nicodemus CF, Findlay SR, Glovsky MM, Grossman J, Kaiser H, et al. Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 1995;95:923-32.
64. Vignola AM, Kips J, Bousquet J. Tissue remodeling as a feature of persistent asthma. J Allergy Clin Immunol 2000;105:1041-53.
65. Bousquet J, Chanez P, Lacoste JY, White R, Vic P, Godard P, et al. Asthma: a disease remodeling the airways. Allergy 1992;47:3-11.
66. Iikura Y, Naspitz CK, Mikawa H, Talaricoficho S, Baba M, Sole M, et al. Prevention of asthma by ketotifen in infants with atopic dermatitis. Ann Allergy 1992;68:233-6.
67. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: first results of ETAC. Early Treatment of the Atopic Child. Pediatr Allergy Immunol 1998;9:116-24.